REVENUES (Tables)
|
6 Months Ended |
Jun. 30, 2023 |
|---|
| REVENUES |
|
| Schedule of revenues disaggregated by category |
Revenues disaggregated by category were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
Product sales: |
|
|
|
|
|
|
|
|
|
|
|
|
Gross product sales |
|
$ |
33,456 |
|
$ |
26,427 |
|
$ |
66,654 |
|
|
49,045 |
Discounts and allowances |
|
|
(9,575) |
|
|
(7,877) |
|
|
(19,028) |
|
|
(14,298) |
Total product sales, net |
|
|
23,881 |
|
|
18,550 |
|
|
47,626 |
|
|
34,747 |
Revenues from collaborations: |
|
|
|
|
|
|
|
|
|
|
|
|
License revenues |
|
|
— |
|
|
2,337 |
|
|
— |
|
|
2,545 |
Development milestones |
|
|
— |
|
|
5,000 |
|
|
— |
|
|
5,000 |
Royalty, delivery of drug supplies and others |
|
|
2,005 |
|
|
3,932 |
|
|
4,330 |
|
|
4,262 |
Total revenues from collaborations |
|
|
2,005 |
|
|
11,269 |
|
|
4,330 |
|
|
11,807 |
Government contract |
|
|
1,000 |
|
|
— |
|
|
1,000 |
|
|
— |
Total revenues |
|
$ |
26,886 |
|
$ |
29,819 |
|
$ |
52,956 |
|
$ |
46,554 |
|
| Schedule of product revenue allowance and reserve categories |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chargebacks, |
|
Government |
|
|
|
|
|
|
Discounts and |
|
and Other |
|
|
|
|
|
|
Fees |
|
Rebates |
|
Returns |
|
Total |
Balance as of January 1, 2023 |
|
$ |
6,213 |
|
$ |
2,636 |
|
$ |
3,296 |
|
$ |
12,145 |
Provision related to current period sales |
|
|
14,439 |
|
|
3,725 |
|
|
395 |
|
|
18,559 |
Credit or payments made during the period |
|
|
(13,139) |
|
|
(3,765) |
|
|
(116) |
|
|
(17,020) |
Balance as of June 30, 2023 |
|
$ |
7,513 |
|
$ |
2,596 |
|
$ |
3,575 |
|
$ |
13,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chargebacks, |
|
Government |
|
|
|
|
|
|
|
|
Discounts and |
|
and Other |
|
|
|
|
|
|
|
|
Fees |
|
Rebates |
|
Returns |
|
Total |
Balance as of January 1, 2022 |
|
$ |
3,404 |
|
$ |
2,494 |
|
$ |
2,017 |
|
$ |
7,915 |
Provision related to current period sales |
|
|
9,680 |
|
|
2,711 |
|
|
613 |
|
|
13,004 |
Credit or payments made during the period |
|
|
(7,748) |
|
|
(2,901) |
|
|
(39) |
|
|
(10,688) |
Balance as of June 30, 2022 |
|
$ |
5,336 |
|
$ |
2,304 |
|
$ |
2,591 |
|
$ |
10,231 |
|
| Schedule of revenues from product sales disaggregated by customers |
The following table summarizes the percentages of revenues from each of our customers who individually accounted for 10% or more of the total net product sales and revenues from collaborations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
2023 |
|
2022 |
|
|
2023 |
|
2022 |
McKesson Specialty Care Distribution Corporation |
|
|
44% |
|
|
34% |
|
|
|
45% |
|
|
36% |
Cardinal Healthcare |
|
|
28% |
|
|
16% |
|
|
|
26% |
|
|
20% |
ASD Healthcare and Oncology Supply |
|
|
19% |
|
|
12% |
|
|
|
21% |
|
|
19% |
Kissei |
|
|
— |
|
|
25% |
|
|
|
— |
|
|
16% |
|